Recurrence of pneumococcal sepsis caused by an intermediately penicillin-resistant organism treated with loracarbef

Pediatric Infectious Disease Journal

Volumn 15, Issue 4, 1996, Pages 379-380

  Shandler, Laurence ^a   Gonzales, Janis ^a   Overturf, Gary D ^a,b  

^a Santa Fe Surgical Associates   (United States)

^b UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

Oral cephalosporins; Penicillin resistant; Streptococcus pneumoniae

Indexed keywords

CEFACLOR; CEFIXIME; CEFOTAXIME; CEFUROXIME; CEPHALOSPORIN DERIVATIVE; CLINDAMYCIN; COTRIMOXAZOLE; LORACARBEF; MACROLIDE; PENICILLIN G;

ARTICLE; CASE REPORT; DOSE RESPONSE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LOBAR PNEUMONIA; MALE; MINIMUM INHIBITORY CONCENTRATION; ORAL DRUG ADMINISTRATION; OTITIS MEDIA; PENICILLIN RESISTANCE; PRESCHOOL CHILD; PRIORITY JOURNAL; RECURRENT INFECTION; SEPSIS; STREPTOCOCCUS PNEUMONIAE;

BACTEREMIA; CEPHALOSPORINS; DRUG RESISTANCE, MICROBIAL; HUMANS; INFANT; MALE; PNEUMOCOCCAL INFECTIONS; RECURRENCE;

EID: 0030005729     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-199604000-00020     Document Type: Article

References (10)

1. Friedland IR, Shelton GE, Paris M, et al. Dilemmas in the diagnosis of and management of cephalosporin-resistant S. pneumoniae meningitis. Pediatr Infect Dis J 1993;12:196-200.
2. Catalan MJ, et al. Failure of cefotaxime in the treatment of meningitis due to relatively resistant Streptococcus pneumoniae. Clin Infect Dis 1994;18:766-9.
3. Tan TQ, Schutze GE, et al. Antibiotic therapy and outcome of meningitis due to Streptococcus pneumoniae considered intermediately susceptible to broad spectrum cephalosporins. Antimicrob Agents Chemother 1994;38:918-23.
4. John CC. Treatment failure with the use of third-generation cephalosporins for penicillin resistant pneumococcal meningitis: case report and review. Clin Infect Dis 1994;18:188-93.
5. Krisher KK, Linscott A. Comparison of three commercial MIC systems, E test, fastidious antimicrobial susceptibility panel, and FOX fastidious panel, for confirmation of penicillin and cephalosporin resistance in S. pneumoniae. J Clin Microbiol 1994;32:2242-5.
6. Lefevre JC, Faucon G, Sicard AM, et al. DNA fingerprinting of Streptococcus pneumoniae by pulsed-field gel electrophoresis. J Clin Microbiol 1993;31:2724-8.
7. Nelson CT, Mason EO, Kaplan SL. Activity of oral antibiotics in middle ear and sinus infections caused by penicillin-resistant Streptococcus pneumoniae: implications for treatment. Pediatr Infect Dis J 1994;13:585-9.
8. Handwerger S, Tomasz A. Alterations in penicillin-binding proteins of clinical and laboratory isolates of pathogenic Streptococcus pneumoniae with low levels of penicillin resistance. J Infect Dis 1986;153:83-9.
9. Jacoby, G. Prevalence and resistance mechanisms of common bacterial respiratory pathogens. Clin Infect Dis 1994;18:951-7.
10. Tan Q, Mason EO, Kaplan SL. Systemic infections due to S. pneumoniae, relatively resistant to penicillin in a children's hospital: clinical management and outcome. Pediatrics 1992;90:928-33.